SCHEMBL22158398

SCHEMBL22158398

N#Cc1c(-n2c3ccccc3c3ccc4c(c5ccccc5n4-c4ccccc4)c32)cc(-c2cc(F)cc(F)c2)cc1-n1c2ccccc2c2ccc3c(c4ccccc4n3-c3ccccc3)c21

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
ATM Q13315 1/20 0.40
PGR P06401 1/20 0.37
JAK2 O60674 1/20 0.37
JAK3 P52333 1/20 0.37
ALDH1A1 P00352 3/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 2/20 0.30
HSD17B10 Q99714 2/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
BRCA1 P38398 1/20 0.30
KMT2A Q03164 1/20 0.30
NRP1 O14786 1/20 0.30
MAPT P10636 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22158391 0.91 KDM4E (0.44) KDM4EL3MBTL1ATMPGRJAK2
SCHEMBL25903056 0.90 KDM4E (0.43) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL25903077 0.89 KDM4E (0.42) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL22158462 0.88 KDM4E (0.39) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL21414303 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMPGRJAK2
SCHEMBL25903197 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL25903344 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL22156852 0.87 KDM4E (0.38) KDM4EL3MBTL1ATMPGRJAK2
SCHEMBL25903799 0.87 KDM4E (0.40) KDM4EL3MBTL1ATMJAK2JAK3
SCHEMBL25903481 0.87 KDM4E (0.40) KDM4EL3MBTL1ATMJAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3635070-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-04-28 EP disclosed
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203628-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 KDM4E 4239/4885L3MBTL1 4126/4885ATM 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.